Holm Rolf Pringler, Pontieri Luigi, Wandall-Holm Malthe Faurschou, Framke Elisabeth, Sellebjerg Finn, Magyari Melinda
The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Valdemar Hansens Vej 2, 2600 Glostrup, Denmark.
The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Valdemar Hansens Vej 2, 2600 Glostrup, Denmark.
Mult Scler Relat Disord. 2023 Mar;71:104546. doi: 10.1016/j.msard.2023.104546. Epub 2023 Feb 3.
The clinical transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) is often related to a period of diagnostic uncertainty delaying diagnosis. With emerging treatment options for SPMS how to identify RRMS patients at risk of SPMS and when to assign a SPMS diagnosis has become a matter of growing clinical concern. This study aimed to determine the period of diagnostic uncertainty among Danish MS patients. Secondly, this study examined the performance of two objective classifiers in a longitudinal setting regarding their ability to shorten the period of diagnostic uncertainty.
By using the Danish Multiple Sclerosis Registry, we identified all patients linked to Rigshospitalet with clinically assigned SPMS from 2010 to 2021. We reviewed all patient records and identified the first mentioned sign of progression (FMP). The time between the dates of FMP and clinically assigned SPMS was defined as the period of diagnostic uncertainty. Secondly, we applied two objective classifiers (the Karolinska Decision tree and the MSBase criteria) to generate suggested transition dates and compared them to the ones obtain from the patient records. Detailed descriptions of the population were made at all mentioned timepoints.
In total 138 patients were included. We found a median period of diagnostic uncertainty of 2.12 years. The objective classifiers generated a median suggested transition date 3.44 and 4.48 years earlier than the date of clinically assigned SPMS, but they only provided an earlier SPMS transition date in 50.72% and 55.80% of cases.
Our findings emphasize the uncertainty related to the transition from RRMS to SPMS illustrating the need of an improved diagnostic approach. Objective classifiers might have the potential to help reduce the period of diagnostic uncertainty in the future, but in their current form they do not perform satisfactorily enough to solve all difficulties related to detecting SPMS-transition.
复发缓解型多发性硬化症(RRMS)向继发进展型多发性硬化症(SPMS)的临床转变通常与一段诊断不确定期相关,这会延迟诊断。随着SPMS新治疗方案的出现,如何识别有SPMS风险的RRMS患者以及何时做出SPMS诊断已成为临床日益关注的问题。本研究旨在确定丹麦MS患者的诊断不确定期。其次,本研究在纵向环境中检验了两种客观分类方法缩短诊断不确定期的能力。
通过丹麦多发性硬化症登记处,我们确定了2010年至2021年期间与里格霍斯医院临床诊断为SPMS相关的所有患者。我们查阅了所有患者记录,并确定了首次提及的进展迹象(FMP)。FMP日期与临床诊断为SPMS的日期之间的时间定义为诊断不确定期。其次,我们应用两种客观分类方法(卡罗林斯卡决策树和MSBase标准)生成建议的转变日期,并将其与从患者记录中获得的日期进行比较。在所有提及的时间点对研究人群进行了详细描述。
共纳入138例患者。我们发现诊断不确定期的中位数为2.12年。客观分类方法生成的建议转变日期中位数比临床诊断为SPMS的日期早3.44年和4.48年,但它们仅在50.72%和55.80%的病例中提供了更早的SPMS转变日期。
我们的研究结果强调了RRMS向SPMS转变的不确定性,表明需要改进诊断方法。客观分类方法可能有潜力在未来帮助缩短诊断不确定期,但以其目前的形式,它们的表现还不足以解决与检测SPMS转变相关的所有困难。